The use of methylphenidate in children and adolescents in France from 2010 to 2015
To describe the use of methylphenidate in children and adolescents in France from 2010 to 2015
Study Type
OBSERVATIONAL
Enrollment
1
Children and adolescents who are users of methylphenidate, 2010 to 2015
Hôpital Robert Debré, APHP
Paris, France
use of methylphenidate over time
Describe of the use of methylphenidate over time to determine the impact of regulatory information of appropriate prescription conditions of use in September 2012
Time frame: 6 years
Describe methylphenidate patterns of use over time
Pharmaceutical specialties (immediate or extended release forms) prescribed by type of delivery: initial or renewals. Profile of prescribers: hospital or private practice (general practitioners, specialists) depending on type of prescription (initial or renewal); geographical distribution of the prescribers Profile of patients: sex, average age and age classes (0-23 months, 2-5 years, 6-11 years, 12-17 years), socioeconomic status, long-lasting diseases status for psychosis, severe personality disorder, mental retardation. Pattern of methylphenidate use: duration of treatment, prolonged use, interruption of treatment.
Time frame: 6 years
Co-prescription of methylphenidate and non-psychostimulant psychotropic drugs
Time frame: 6 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.